New Trial of Lu-177-PSMA-617 to begin April 30, 2021.
., Taxotere, Jevtana, carboplatin, etc.), an immunotherapy, or any other PSMA-targeted therapy. Xofigo is allowed if it was used more than 6 months ago. Treatment with and resistance to at least one advanced hormonal therapy is required.
., Taxotere, Jevtana, carboplatin, etc.), an immunotherapy, or any other PSMA-targeted therapy. Xofigo is allowed if it was used more than 6 months ago. Treatment with and resistance to at least one advanced hormonal therapy is required.